Chinese airlines are offering tickets at what are known colloquially as “cabbage” prices as they start restoring seat capacity following drastic capacity cuts enforced by the COVID-19 outbreak.
A one-way direct trip from Shanghai to Chengdu on Juneyao Airlines Co (吉祥航空) on Saturday costs just 90 yuan (US$12.89) plus 50 yuan in taxes.
That is a three-and-a-half-hour journey, about the same as a flight from New York to New Orleans.
Chinese carriers are adding nearly 3 million seats back into scheduled services this week, primarily for domestic routes, OAG Aviation Worldwide reported.
“The dramatic capacity recovery has led to very low fares being made available,” analyst John Grant wrote.
China Southern Airlines Co (中國南方航空) is adding 684,000 seats and China Eastern Airlines Corp (中國東方航空) is increasing capacity by 566,000 seats, Grant said.
China’s overall capacity is still only about half the 16.9 million seats available as of Jan. 20, when there were only hundreds of reported COVID-19 infections.
Chinese airlines posted losses of more than 10 billion yuan last month as revenue fell 37 billion yuan, Sina.com (新浪) reported, citing industry estimates.
While the picture turns more positive for China, the South Korea and Hong Kong markets are still sharply reducing capacity, both by more than 20 percent this week, OAG reported.
Since Jan. 20, Hong Kong’s capacity has slumped 71 percent, with Cathay Pacific Airways Ltd (國泰航空) shrinking from more than 400,000 seats to 119,860, OAG said.
The International Air Transport Association on Feb. 20 said that the outbreak could result in a 13 percent drop in passenger demand for airlines in the Asia-Pacific region this year, translating into a revenue loss of US$27.8 billion.
The bulk of that would be borne by carriers registered in China, with US$12.8 billion in losses, it said.
Among the rows of vibrators, rubber torsos and leather harnesses at a Chinese sex toys exhibition in Shanghai this weekend, the beginnings of an artificial intelligence (AI)-driven shift in the industry quietly pulsed. China manufactures about 70 percent of the world’s sex toys, most of it the “hardware” on display at the fair — whether that be technicolor tentacled dildos or hyper-realistic personalized silicone dolls. Yet smart toys have been rising in popularity for some time. Many major European and US brands already offer tech-enhanced products that can enable long-distance love, monitor well-being and even bring people one step closer to
Malaysia’s leader yesterday announced plans to build a massive semiconductor design park, aiming to boost the Southeast Asian nation’s role in the global chip industry. A prominent player in the semiconductor industry for decades, Malaysia accounts for an estimated 13 percent of global back-end manufacturing, according to German tech giant Bosch. Now it wants to go beyond production and emerge as a chip design powerhouse too, Malaysian Prime Minister Anwar Ibrahim said. “I am pleased to announce the largest IC (integrated circuit) Design Park in Southeast Asia, that will house world-class anchor tenants and collaborate with global companies such as Arm [Holdings PLC],”
Sales in the retail, and food and beverage sectors last month continued to rise, increasing 0.7 percent and 13.6 percent respectively from a year earlier, setting record highs for the month of March, the Ministry of Economic Affairs said yesterday. Sales in the wholesale sector also grew last month by 4.6 annually, mainly due to the business opportunities for emerging applications related to artificial intelligence (AI) and high-performance computing technologies, the ministry said in a report. The ministry forecast that retail, and food and beverage sales this month would retain their growth momentum as the former would benefit from Tomb Sweeping Day
Thousands of parents in Singapore are furious after a Cordlife Group Ltd (康盛人生集團), a major operator of cord blood banks in Asia, irreparably damaged their children’s samples through improper handling, with some now pursuing legal action. The ongoing case, one of the worst to hit the largely untested industry, has renewed concerns over companies marketing themselves to anxious parents with mostly unproven assurances. This has implications across the region, given Cordlife’s operations in Hong Kong, Macau, Indonesia, the Philippines and India. The parents paid for years to have their infants’ cord blood stored, with the understanding that the stem cells they contained